Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
iShares Biotechnology ETF (IBB)
USD189.55
-2.51 (-1.31%)
NASDAQ USD US Equity
NAV
USD 192.09
-1.32% vs NAV
as of 2026-07-13
AUM
USD 9.35B
TER
0.44%
Yield (TTM)
0.22%
Distribution
Distributing · Semi-Annual
52-week range
129.05 – 198.23
Holdings
251
Issuer
IShares
About this ETF
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
ISIN
US4642875565
Issuer
IShares
Domicile
US
Inception
2001-02-05
Asset class
Equity
Price
Top 10 holdings
| VERTEX PHARMACEUTICALS INC VRTX | 7.81% |
| AMGEN INC AMGN | 7.76% |
| GILEAD SCIENCES INC GILD | 6.95% |
| REGENERON PHARMACEUTICALS INC REGN | 5.17% |
| ARGENX SE ADR ARGX | 3.51% |
| ALNYLAM PHARMACEUTICALS INC ALNY | 3.06% |
| NATERA INC NTRA | 2.84% |
| REVOLUTION MEDICINES INC RVMD | 2.74% |
| BIOGEN INC BIIB | 2.25% |
| ILLUMINA INC ILMN | 2.21% |
Sector mix
Price chart
USD189.55
-2.51 (-1.31%)
Loading historical data…
Returns
| 1 month | +14.23% |
| 3 months | +11.91% |
| 6 months | +10.04% |
| Year to date | +12.31% |
| 1 year | +41.83% |
| 3 years (ann.) | +14.75% |
| 5 years (ann.) | +2.85% |
| 10 years (ann.) | +8.25% |
Risk profile
| Volatility (1y, ann.) | 20.70% |
| Sharpe (1y) | 1.79 |
| Sharpe (3y) | 0.78 |
| Sortino (1y) | 3.11 |
| Max drawdown (1y) | -9.70% |
| Max drawdown (5y) | -39.95% |
| Max drawdown (full) | -62.86% |
| Beta vs S&P 500 (1y) | 0.81 |
| Correlation vs S&P 500 (1y) | 0.49 |
Technical outlook as of 2026-07-13
Day Score (bias 0-100, not a probability)
57
P(gain) 22 sessions — probability
53%
VaR 95% (daily)
-2.24%
CVaR 95% (daily)
-3.26%
GARCH vol forecast (22d)
1.50%
Market regime (Markov)
Lateral
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Top-10 concentration
44.3%
Effective holdings
35
Disclosed positions
251
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Loading map…
Cost vs. peers
IBB
0.44%
Equity median
0.39%
Cheapest in class BKLC
0.00%
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Distributing share class Income is paid out to shareholders.
| Ex-date | Payment | Amount |
|---|---|---|
| 2026-06-15 | 2026-06-18 | USD 0.0238 |
| 2026-03-17 | 2026-03-20 | USD 0.1218 |
| 2025-12-16 | 2025-12-19 | USD 0.1831 |
| 2025-09-16 | 2025-09-19 | USD 0.0828 |
| 2025-03-18 | 2025-03-21 | USD 0.1212 |
| 2024-12-17 | 2024-12-20 | USD 0.0624 |
| 2024-09-25 | 2024-09-30 | USD 0.2005 |
| 2024-03-21 | 2024-03-27 | USD 0.1260 |
| 2023-12-20 | 2023-12-27 | USD 0.1240 |
| 2023-09-26 | 2023-10-02 | USD 0.1532 |
| 2023-06-07 | 2023-06-13 | USD 0.0062 |
| 2023-03-23 | 2023-03-29 | USD 0.0646 |
| 2022-12-13 | 2022-12-19 | USD 0.1010 |
| 2022-09-26 | 2022-09-30 | USD 0.1590 |
| 2022-06-09 | 2022-06-15 | USD 0.0310 |
| 2022-03-24 | 2022-03-30 | USD 0.1180 |
| 2021-12-13 | 2021-12-17 | USD 0.0410 |
| 2021-09-24 | 2021-09-30 | USD 0.1240 |
| 2021-06-10 | 2021-06-16 | USD 0.0232 |
| 2021-03-25 | 2021-03-31 | USD 0.1310 |
| 2020-12-14 | 2020-12-18 | USD 0.0650 |
| 2020-09-23 | 2020-09-29 | USD 0.0630 |
| 2020-06-15 | 2020-06-19 | USD 0.1270 |
| 2020-03-25 | 2020-03-31 | USD 0.0550 |
| 2019-12-30 | — | USD 0.0630 |
| 2019-12-16 | 2019-12-20 | USD 0.0580 |
| 2019-09-24 | 2019-09-30 | USD 0.0710 |
| 2019-06-17 | 2019-06-21 | USD 0.0800 |
| 2019-03-20 | — | USD 0.1270 |
| 2018-09-26 | 2018-10-02 | USD 0.0320 |
| 2018-06-26 | 2018-07-02 | USD 0.1561 |
| 2017-12-21 | 2017-12-28 | USD 0.1250 |
| 2017-09-26 | 2017-09-29 | USD 0.0397 |
| 2017-06-27 | 2017-06-30 | USD 0.0589 |
| 2017-03-24 | 2017-03-30 | USD 0.0997 |
| 2016-12-22 | 2016-12-29 | USD 0.0307 |
| 2016-09-26 | 2016-09-30 | USD 0.0287 |
| 2016-06-21 | 2016-06-27 | USD 0.0541 |
| 2016-03-23 | 2016-03-30 | USD 0.0509 |
| 2015-12-24 | 2015-12-31 | USD 0.0107 |
Splits
| 2017-12-01 | 3:1 |
ESG profile
Derived from holdings
covers 89.3% of the portfolio by weight
(215 scored constituents)
Environmental
57.8
class avg 63.0
Social
60.7
class avg 62.3
Governance
62.3
class avg 64.9
Total ESG
60.3
class avg 63.4
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| Vanguard Small-Cap ETF VB | 0.03% | 182.70B | 5.6% |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 2.6% |
| Vanguard Value ETF VTV | 0.03% | 245.00B | 1.7% |
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.6% |
| State Street SPDR Portfolio S&P 500 ETF SPYM | 0.02% | 159.32B | 1.0% |
